Benjamin L. Palleiko

Overview

Benjamin L. Palleiko received an average of $2M in total compensation, including $403K in salary, at Carbylan Therapeutics from 2017 to 2023.

Source: SEC filings on August 14, 2023, August 25, 2020, and August 23, 2019.

Related executives

We found six more executives who work or worked at Carbylan Therapeutics.

T Crockett

Carbylan Therapeutics

Chief Executive Officer

Christopher Yea

Carbylan Therapeutics

Chief Development Officer

Edward Feener

Carbylan Therapeutics

Chief Scientific Officer

David Renzi

Carbylan Therapeutics

Chief Operating Officer

Premchandran Ramiya

Carbylan Therapeutics

Vice President, Pharmaceutical Development & Supply Chain

Marcee Maroney

Carbylan Therapeutics

Vice President, Clinical Affairs

News

You may also like